Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 19 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,633 followers.

Our paper got published on this world diabetes day . See the link https://t.co/bglTHnaU6B

14 Nov 2023

Reply Repost Favourite

Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis https://t.co/HDhvAru5vX

07 Nov 2023

Reply Repost Favourite

Dove Medical Press

Article Metrics

Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis

About this Attention Score

Mentioned by

Readers on